Just six months of homocysteine-lowering therapy with vitamins B6, B12 and folic acid can substantially reduce the risk of cardiac events, say Swiss researchers.
Just six months of homocysteine-lowering therapy with vitamins B6, B12 and folic acid can substantially reduce the risk of cardiac events, say Swiss researchers.